The estimated Net Worth of Amit Munshi is at least $14.8 Million dollars as of 16 August 2021. Mr. Munshi owns over 1,000 units of Arena Pharmaceuticals Inc stock worth over $3,954,605 and over the last 9 years he sold ARNA stock worth over $1,930,200. In addition, he makes $8,931,400 as Director and President and Chief Executive Officer at Arena Pharmaceuticals Inc.
Amit has made over 16 trades of the Arena Pharmaceuticals Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he bought 1,000 units of ARNA stock worth $48,190 on 16 August 2021.
The largest trade he's ever made was exercising 100,000 units of Arena Pharmaceuticals Inc stock on 15 January 2021 worth over $1,550,000. On average, Amit trades about 15,809 units every 45 days since 2016. As of 16 August 2021 he still owns at least 39,550 units of Arena Pharmaceuticals Inc stock.
You can see the complete history of Mr. Munshi stock trades at the bottom of the page.
Amit D. Munshi serves as Director, President and Chief Executive Officer of the Company. He has served as a member of our Board of Directors since June 2016, and as our President and Chief Executive Officer since May 2016. Previously, Mr. Munshi served as President and Chief Executive Officer and a director of Epirus Biopharmaceuticals, Inc. from May 2012 to May 2016, and as Chief Executive Officer of Percivia LLC, a biotechnology company, from 2011 to 2012. Prior to Epirus and Percivia, Mr. Munshi was a co-founder and served as Chief Business Officer of Kythera Biopharmaceuticals, Inc., from 2005 to 2010, and held multiple leadership positions at Amgen Inc. from 1997 to 2005, including General Manager, Nephrology Europe. In July 2016, Epirus filed a voluntary Chapter 7 petition in the United States Bankruptcy Court for the District of Massachusetts. Mr. Munshi holds a B.S. in Economics and a B.A. in History from the University of California, Riverside, and an M.B.A. from the Peter F. Drucker School of Management at Claremont Graduate University. Mr. Munshi has more than 28 years of global biopharmaceutical industry experience in executive management, business development, product development and portfolio management. Mr. Munshi currently serves on the board of Pulmatrix, Inc., a biopharmaceutical company developing inhaled therapies to address pulmonary diseases, and also serves as an advisor and lecturer at the Peter F. Drucker School of Management at the Claremont Graduate School.
As the Director and President and Chief Executive Officer of Arena Pharmaceuticals Inc, the total compensation of Amit Munshi at Arena Pharmaceuticals Inc is $8,931,400. There are no executives at Arena Pharmaceuticals Inc getting paid more.
Amit's mailing address filed with the SEC is OLE MAALOES VEJ 3, C/O GALECTO, INC., COPENHAGEN N G7, G7, DK-2200.
Over the last 21 years, insiders at Arena Pharmaceuticals Inc have traded over $9,243,184 worth of Arena Pharmaceuticals Inc stock and bought 78,040 units worth $252,505 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Manmeet Singh Soni, and Garry Arthur Neil. On average, Arena Pharmaceuticals Inc executives and independent directors trade stock every 39 days with the average trade being worth of $3,133,387. The most recent stock trade was executed by Amit Munshi on 16 August 2021, trading 1,000 units of ARNA stock currently worth $48,190.
Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas
Arena Pharmaceuticals Inc executives and other stock owners filed with the SEC include: